from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3877/eccD1

LFCtreatmentdescriptionclass of inhibitor

-1.415

Amikacinug/mL Amikacintranslation

-1.483

Cap5-10ug/mL Capreomycintranslation

-1.845

Rox10-50 ug/mL Roxithromycintranslation

-0.596

SM2-5 ug/mL Streptomycintranslation

-4.042

Tet5-10 ug/mL Tetracyclinetranslation

-0.507

Rif0.2-5ug/mL Rifampicintranscription

0.525

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.276

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.297

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.297

CPZ10-50 ug/mL Chlorpromazinerespiration

0.885

Clofazimine10-13 ug/mL Clofaziminerespiration

0.256

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.580

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.345

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.508

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.480

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.076

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.400

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.515

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.500

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.020

KCN5-20 ug/mL Potassium cyaniderespiration

1.002

NaN30.2-2 mM Sodium aziderespiration

0.195

Nigericin50 uM Nigericinrespiration

-0.044

TRC10-150 ug/mL Triclosanrespiration

0.875

TRZ10-25 ug/mL Thioridazinerespiration

-1.324

Valinomycin0.5-10 uM Valinomycinrespiration

1.328

ZnSO42 mM ZnSO4respiration

0.314

menadione6-10 ug/mL Menadionerespiration

0.256

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.357

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.101

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.240

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.719

NRP_1Non-replicating persistence stage 1dosRassociated

0.658

Amp0.2mg/mL AmpicillincellWall

0.180

Cephalexin20-100 ug/mL CephalexincellWall

0.411

Cerulenin0.32-5 ug/mL CerulenincellWall

0.564

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.643

EMB10-20 ug/mL EthambutolcellWall

0.910

Eta12-40 ug/mL EthionamidecellWall

1.020

INH0.2-0.4 ug/mL IsoniazidcellWall

0.420

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.381

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.445

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.173

BZA0.12 mg/mL BenzamidearomaticAmides

-0.984

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-1.149

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.647

H2O24 mM hydrogen peroxideDNAdamaging

-0.146

Levo10 ug/mL LevofloxacinDNAdamaging

-0.656

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.146

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.539

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.207

UVUV-irradiationDNAdamaging

0.460

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.249

Antimycin12.5-50 ug/mL Antimycin A?

0.303

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.275

PA_110-50 ug/mL Antitubercular compound PA-1?

0.352

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.812

PA8240.2-2 ug/mL PA-824?

0.942

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.273

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.011

Verapamil50 uM Verapamil?

0.017

mercaptoethanol2 mM 2-Mercaptoethanol?

0.147

methoxatin10-20 ug/mL Methoxatin?